icon-folder.gif   Conference Reports for NATAP  
 
  62th Annual Meeting of the American Association for the Study of Liver Diseases San Francisco 2011 Nov 6-9 Back grey_arrow_rt.gif
 
 
 
The Effect of Using Lower Limit of Quantitation (LLQ) vs Lower Limit of Detection (LLD) for the Definition of Undetectable HCV RNA: Data from the RESPOND-2 and SPRINT-2 trials
 
 
  Reported by JulesLevin
AASLD Nov 5-8 2011 SF
 
E. Lawitz1, F. Poordad2, J-P. Bronowicki3, P. Marcellin4, S.V. Feinman5, P. Kwo6, D. Guyader7, M. Davis8, S. Harrison9, L. Pedicone10, R. Jiang10, M. Burroughs10, C. Brass10, J. Albrecht10, S. Zeuzem11
 
1Alamo Medical Research, San Antonio, TX, USA, 2Cedars-Sinai Medical Center, Los Angeles, CA, 3Universite Henri Poincare-Nancy 1, Vandoeuvre-les-Nancy, France, 4University Paris 7-H˘pital Beaujon, Clichy, France, 5Mount Sinai Hospital, 6Indiana University School of Medicine, 7C.H.R.U. de Rennes, Hopital de Pontchaillou, 8South Florida Center of Gastroenterology, Wellington, FL, 9Brooke Army Medical Center, Fort Sam Houston, TX, 10Merck, Whitehouse Station, NJ, 11J.W. Goethe University Hospital, Frankfurt, Germany.

AASLD1.gif

AASLD2.gif

AASLD3.gif

AASLD4.gif

AASLD5.gif

AASLD6.gif

AASLD7.gif

AASLD8.gif